Maple Syrup Disease Testing
Maple syrup urine disease (MSUD) is a rare, autosomal recessive genetic disease with incidence estimates of 1:185,000 live births. It is more common in certain Mennonite populations of Kentucky, New York, Indiana, Wisconsin, Michigan, Pennsylvania, Iowa, and Missouri with a carrier frequency of 1:10 and incidence rate of ~1:380 live births. The most common form of MSUD can be characterized within 12-24 hours of birth through the presence of a maple syrup-like sweet odor in the urine and elevated branched-chain amino acid concentrations. Further characteristics of MSUD are apparent by 2-3 days post-birth including irritability, ketonuria, and poor feeding. If left untreated, MSUD can lead to seizures, coma, and death within 7-10 weeks post-birth. A milder form of MSUD can be present later in infancy or childhood with symptoms including anorexia, irritability, poor growth, and/or developmental delays.
MSUD is caused by deficiency of the branched-chain-ketoacid dehydrogenase (BCKDH) complex. This complex is involved in the metabolism of branched-chain amino acids: valine (Val), leucine (Leu), isoleucine (Ile), and allo-isoleucine. MSUD is diagnosed based on clinical manifestations and decreased levels of BCKAD activity causing increased levels of leucine, valine, isoleucine, allo-isoleucine, and branched-chain ketoacids in tissues and plasma.
MSUD is caused by mutations in the BCKDHA, BCKDHB, DBT, and DLD genes. These four genes are essential for breaking down the amino acids valine, leucine, isoleucine, and allo-isoleucine that are present in protein-rich foods such as eggs, milk, and meat. Gene mutations reduce or eliminate the function of the protein complex, preventing the normal breakdown of these amino acids and, as a result, their byproducts accumulate in the body. The increased levels of byproducts lead to serious medical problems associated with MSUD.
- Diagnosis of maple syrup disease
- Confirmation of maple syrup disease
- Prenatal diagnosis of maple syrup disease
- Determine carrier status (carrier screening)
Increased amino acids valine, leucine, isoleucine, and alo-isoleucine indicates disease.
If genetic testing is performed, heterozygous mutations in one or more genes (BCKDHA, BCKDHB, DBT, and DLD) might indicate carrier status.
Compound heterozygous or homozygous mutations in one or more of these genes BCKDHA, BCKDHB, DBT, and DLD might be diagnostic for the disease.
For Genetic Testing: Negative for mutations analysed
Amino Acid Levels:
VALINE
· Premature: 99-220 nmol/mL
· 1-31 days: 86-190 nmol/mL
· 32 days-23 months: 64-294 nmol/mL
· 2-18 years: 74-321 nmol/mL
· > or = 19 years: 119-336 nmol/mL
LEUCINE
· Premature: 151-220 nmol/mL
· 1-31 days: 48-160 nmol/mL
· 32 days-23 months: 47-155 nmol/mL
· 2-18 years: 49-216 nmol/mL
· > or = 19 years: 72-201 nmol/mL
ISOLEUCINE
· Premature: 23-85 nmol/mL
· 1-31 days: 26-91 nmol/mL
· 32 days-23 months: 31-86 nmol/mL
· 2-18 years: 22-107 nmol/mL
· > or = 19 years: 30-108 nmol/mL
ALLO-ISOLEUCINE
· Applies to all ages: 0-2 nmol/mL
Blood
For Amino Acid Levels: whole blood, green-top (sodium heparin) tube preferred. EDTA or lithium heparin acceptable. 0.5 ML minimum. No gel separation tubes. Infants should be drawn immediately before feeding. Plasma used for testing, transport frozen. May remain frozen for 14 days.
If genetic testing performed blood should be collected in lavender top tube (EDTA).
Stability
- Ambient: 5 days
- Refrigerated: 7-14 days
- J Pediatr. 2011 Aug 10. [PMID: 21839471]
- Clin Chem. 1999a;45:1734-40 [PMID: 10508118].
- Mol Genet Metab. 2003;80:189-95. [PMID: 14567968]
- Am J Med Genet C Semin Med Genet. 2003;121C:18-31. [PMID: 12888983]
- Am J Hum Genet. 2001;68:232-7. [PMID: 11112664]
- The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill. pp:1971-2006 (2001).
- Amino acids. In The Metabolic and Molecular Bases of Inherited Disease. 8th edition. Edited by CR Scriver, AL Beaudet, WS Sly, et al. New York, McGraw-Hill, Inc. pp 1667-2105 (2001)
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757